Literature DB >> 21868369

Treatment of sydenham chorea with intravenous immunoglobulin.

Kathleen Walker1, Anita Brink, John Lawrenson, Wendy Mathiassen, Jo M Wilmshurst.   

Abstract

Sydenham chorea is a post-streptococcal, autoimmune, neuropsychiatric, movement disorder. There is no effective treatment. In a randomized study, comparison was made of the outcomes of 10 children treated with standard management alone compared to 10 who received additional intravenous immunoglobulin. The outcomes were assessed using a clinical rating scale, brain single-photon emission computed tomography, and the duration of symptomatic treatment. All three outcome measurement tools found improved outcomes in the group that received intravenous immunoglobulin.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21868369     DOI： 10.1177/0883073811414058

Source DB:  PubMed          Journal:  J Child Neurol        ISSN： 0883-0738            Impact factor:   1.987


  13 in total

Review 1.  Treatment of Disorders of Tone and Other Considerations in Pediatric Movement Disorders.

Authors:  Stephen R Deputy; Ann H Tilton
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

Review 2.  Treatment of movement disorder emergencies.

Authors:  Steven J Frucht
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

3.  Neuropsychological manifestations in children with Sydenham's chorea after adjunct intravenous immunoglobulin and standard treatment.

Authors:  Claire Gregorowski; Christine Lochner; Lindi Martin; Candice Simmons; Martin Kidd; Kathleen Walker; Jo M Wilmshurst; Soraya Seedat
Journal:  Metab Brain Dis       Date:  2015-05-19       Impact factor: 3.584

4.  Use of intravenous immunoglobulin in the treatment of twelve youths with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

Authors:  Miro Kovacevic; Paul Grant; Susan E Swedo
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-02-06       Impact factor: 2.576

Review 5.  The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data.

Authors:  Giovanna Vitaliti; Omidreza Tabatabaie; Nassim Matin; Caterina Ledda; Piero Pavone; Riccardo Lubrano; Agostino Serra; Paola Di Mauro; Salvatore Cocuzza; Raffaele Falsaperla
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Successful treatment of Sydenham's chorea with intravenous immunoglobulin.

Authors:  Nienke Anne Boersma; Herman Schippers; Taco Kuijpers; Jojanneke Heidema
Journal:  BMJ Case Rep       Date:  2016-02-01

7.  Severe Sydenham's chorea (chorea paralytica) successfully treated with plasmapheresis.

Authors:  Marcelo Miranda; Ruth H Walker; David Saez; Victoria Renner
Journal:  J Clin Mov Disord       Date:  2015-01-21

Review 8.  Treatment of Sydenham's Chorea: A Review of the Current Evidence.

Authors:  Shannon L Dean; Harvey S Singer
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-06-01

Review 9.  Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations.

Authors:  Liesl J Zühlke; Andrea Beaton; Mark E Engel; Christopher T Hugo-Hamman; Ganesan Karthikeyan; Judith M Katzenellenbogen; Ntobeko Ntusi; Anna P Ralph; Anita Saxena; Pierre R Smeesters; David Watkins; Peter Zilla; Jonathan Carapetis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

10.  Sydenham Chorea Managed With Immunoglobulin in Acute Rheumatic Fever.

Authors:  Asim Ali; Gibson O Anugwom; Usama Rehman; Muhammad Zain Khalid; Mohammad Omar Saeeduddin
Journal:  Cureus       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.